Vaccines: From Concept to Immunization
With over 17 million* confirmed cases of COVID-19 worldwide, there is a renewed focus on vaccine development for disease prevention and mitigation.
Join us as we spotlight this hot topic in a free webinar designed to educate everyone from the citizen scientist and casual student to those working in life sciences and healthcare.
Masha Fridkis-Hareli, WPI adjunct professor and 20+ year industry expert, provides a high-level overview of the vaccine development process and offer insight into the variables considered during production.
Fill out the form to view the webinar.
Did you know? WPI is launching a technical short course this fall, Vaccines: From Concept to Immunization. Learn more about this 4-week course.
This webinar will cover the following topics:
- Intro to Basic Immunology
- Types of Vaccines
- How Vaccinations Work
- Why Vaccines Fail
- Vaccine Development Process
- Vaccine Manufacturing
- Vaccine Clinical Trials
- Vaccine Regulation (FDA)
- Globalization, Outsourcing Concerns, International Cooperation
- PPE Equipment (China)
- Diagnostic Testing (WHO, CDC, Public vs. Private Labs & Universities)
- Vaccine Manufacturing (India)
Masha Fridkis-Hareli is a successful immunologist, consultant and inventor with extensive expertise in autoimmune and inflammatory diseases and particular emphasis on cellular and protein-based assays, in vitro pharmacology and preclinical immunotoxicology. Marsha contributed to the discovery and development of Taligen’s drug pipeline leading to acquisition by Alexion Pharmaceuticals and designed and developed a group of novel compounds for treatment of autoimmune diseases: drug candidate PI-2301 is being tested in Phase II clinical trials for multiple sclerosis.
*This webinar was originally conducted in June, 2020
For questions, please contact:
Senior Manager, Healthcare Corporate Partnerships, WPI
Got 7 minutes? Take this short survey and help improve the
Take me to the webinar